Today: March 22, 2019 9:39 am
Location Kit

Tag: pharmaceutical products


SYNEOS SHAREHOLDER ALERT BY COACH LOUISIANA GENERAL COACH: KAHN SWICK & amp; FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $ 100,000 Most important Declare Plaintiff in Motion in opposition to Syneos Well being, Inc. – SYNH
March 9, 2019

SYNEOS SHAREHOLDER ALERT BY COACH LOUISIANA GENERAL COACH: KAHN SWICK & amp; FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $ 100,000 Most important Declare Plaintiff in Motion in opposition to Syneos Well being, Inc. – SYNH

New Orleans, March 8, 2019 / PRNewswire / – Kahn Swick & Foti, LLC ("KSF") and KSF associate, shaped by the Lawyer Common of Louisiana, Charles C. Foti, Jr., remind traders that they’ve as much as April 30, 2019 file main claimants' purposes in a category motion lawsuit in opposition to Syneos Well being, Inc. (NasdaqGS: SYNH) Might 10, 2017 Y February 27, 2019, inclusive (the "Class Interval"). This motion is pending in the USA District Court docket for the District of New Jersey. What you are able to do In the...

Continue Reading
Share
MEI Pharma presents preclinical information demonstrating that Voruciclib synergistically induces apoptosis together with venetoclax in acute myeloid leukemia cells on the annual assembly of the American Society of Hematology 2018
December 2, 2018

MEI Pharma presents preclinical information demonstrating that Voruciclib synergistically induces apoptosis together with venetoclax in acute myeloid leukemia cells on the annual assembly of the American Society of Hematology 2018

SAN DIEGO, December 1, 2018 / PRNewswire / – MEI Pharma, Inc. (NASDAQ: MEIP), an advanced-stage pharmaceutical firm targeted on advancing new therapies for most cancers, right now introduced preclinical information offered on the annual assembly of the American Society of Hematology (ASH). ) from 2018 demonstrating that voruciclib Inhibited, clinically induced CDK9 inhibitor, synergistically induced apoptosis at clinically related concentrations when mixed with venetoclax (marketed as Venclexta®) in human derived acute myeloid leukemia (AML) traces and affected person samples. Voruciclib is at present being evaluated in a Part. 1 B Dose...

Continue Reading
Share
A Washington court approves a $ 14.25 million class action settlement for women who used a religious bath where the Georgetown rabbi made secret registrations
November 21, 2018

On November 16, 2018, Cedrus Investments signed a cooperation settlement with Sinopharm Nutraceuticals Industrial (Shanghai)

SHANGHAI, November 21, 2018 / PRNewswire / – cedrus Investments (" cedrus "), a world funding firm, has signed a cooperation settlement with Sinopharm Nutraceuticals Industrial (Shanghai("Sinopharm Nutraceuticals"), November 16, 2018 a Shanghai, to review and implement Investments within the pharmaceutical, well being and biotechnology sectors., making the most of the assets and strengths of every one. Underneath this settlement, Cedrus supplies entry to its proprietary transaction flows from world wide, superior technical expertise within the biopharmaceutical sector, diversified worldwide enterprise expertise and the power to construction and execute transactions: acquisitions. and...

Continue Reading
Share
A Washington court approves a $ 14.25 million class action settlement for women who used a religious bath where the Georgetown rabbi made secret registrations
November 7, 2018

VolitionRx Restricted publicizes the monetary outcomes and the industrial replace for the third quarter of 2018

Cameron ReynoldsThe President and CEO of Volition mentioned: "We’ve got made nice progress on this space, typically, with more often than not of completion of a personal placement (PIPE). $ 9 million (excluding any product from the train of the order); guaranteeing an extra $ 700,000 in non-dilutive funds of the Walloon regional authorities; and extra not too long ago, the train of excellent ensures that supplied roughly $ 717,000 In further funds to the corporate. " Mr. Reynolds commented: "The primary investigation can be launched sooner or later and is anticipated...

Continue Reading
Share
A Washington court approves a $ 14.25 million class action settlement for women who used a religious bath where the Georgetown rabbi made secret registrations
October 29, 2018

Oxurion NV broadcasts the appointment of Adrienne Graves on its Board of Administrators

Louvain, Belgium, October 29, 2018 / PRNewswire / – Oxurion NV (Euronext Brussels: OXUR – previously generally known as ThromboGenics Nevada), a biopharmaceutical firm that develops modern remedies to protect imaginative and prescient within the eyes of sufferers with eye ailments, at the moment introduced the appointment of Adrienne Graves, Ph.D., to its board of administrators. Dr. Graves will substitute Paul howes, who has been a board member since 2014. "I'm honored to be named for the blackboard of administrators in Oxurion, " mentioned Dr. Critical "The corporate has constructed a various...

Continue Reading
Share
A Washington court approves a $ 14.25 million class action settlement for women who used a religious bath where the Georgetown rabbi made secret registrations
October 28, 2018

The 2-year knowledge for Novartis brolucizumab reaffirm the prevalence to aflibercept in fluid discount in sufferers with DMN

HANOVER DEL ESTE, N.J., October 27, 2018 / PRNewswire / – Novartis declares further outcomes of second section brolucizumab Part III that reaffirmed optimistic first 12 months outcomes. Brolucizumab places its main endpoint of noninferiority to aflibercept in one of the best corrected visible acuity (MCVA) and confirmed a superiority in the important thing retinal ends in one (48 weeks)1.2. The secondary endpoints in two years (96 weeks) reaffirmed the prevalence of brolucizumab 6 mg within the discount of retinal fluid, an vital marker of illness exercise in sufferers with age-related macular...

Continue Reading
Share